2019
DOI: 10.1007/s40268-019-0272-1
|View full text |Cite
|
Sign up to set email alerts
|

Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA

Abstract: Dementia affects all domains of cognition. The relentless progression of the disease after diagnosis is associated with a 98% incidence of neuropsychiatric symptoms (NPS) at some point in the disease, including depression, psychosis, agitation, aggression, apathy, sleep disturbances, and disinhibition. These symptoms can be severe and lead to excess morbidity and mortality. The purpose of this article was to describe current literature on the medication management of NPS of dementia and highlight approaches to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(32 citation statements)
references
References 122 publications
0
32
0
Order By: Relevance
“…Sleep disturbances are frequent in AD patients and are related to age changes in sleep patterns, medication effects, comorbidity with anxiety, depression, and to the neurodegenerative disease by itself ( 18 ). Sleep disorders are disruptive to caregivers and increase the rate of institutionalization and caregiver burnout ( 22 , 23 ). Strategies to improve sleep quality include sleep hygiene, physical activity during the day, and keeping a structured daily routine ( 22 , 23 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Sleep disturbances are frequent in AD patients and are related to age changes in sleep patterns, medication effects, comorbidity with anxiety, depression, and to the neurodegenerative disease by itself ( 18 ). Sleep disorders are disruptive to caregivers and increase the rate of institutionalization and caregiver burnout ( 22 , 23 ). Strategies to improve sleep quality include sleep hygiene, physical activity during the day, and keeping a structured daily routine ( 22 , 23 ).…”
Section: Discussionmentioning
confidence: 99%
“…Sleep disorders are disruptive to caregivers and increase the rate of institutionalization and caregiver burnout ( 22 , 23 ). Strategies to improve sleep quality include sleep hygiene, physical activity during the day, and keeping a structured daily routine ( 22 , 23 ). These strategies were all compromised during this lockdown period, and sleep difficulties were overall frequent, with even higher prevalence in subjects with mild dementia.…”
Section: Discussionmentioning
confidence: 99%
“… 41 44 However, there is limited efficacy in use of pharmacologic agents, and the side-effect profile needs to be carefully weighed against potential benefits. 40 For instance, atypical antipsychotics can lead to excess sedation, metabolic side effects, and EPS. In addition, a boxed warning from the FDA alerts prescribers to the increased risk of death associated with use of atypical antipsychotics in elderly patients with dementia-related psychotic symptoms.…”
Section: Resultsmentioning
confidence: 99%
“…Managing agitation in patients with dementia should be largely non-pharmacological, when possible, as there is an evidence base supporting a number of such interventions. 39,40 In Alzheimer dementia, in addition to the decline noted in cholinergic neurotransmission, the accumulation of amyloid plaques and neurofibrillary tangles may result in glutamatergic release, with potential for excitotoxicity. Available pharmacologic options include atypical antipsychotics (e.g., risperidone and olanzapine), antiepileptics (e.g., carbamazepine, gabapentin), serotonergic agents, and even less conventional options such as dextromethorphan/ quinidine combination, the latter possessing antiglutamatergic properties.…”
Section: Management Of Agitation -Pharmacological Optionsmentioning
confidence: 99%
“…Moreover, conventional psychotropic drugs often overprescribed in AD, such as antipsychotics and Selective-Serotonin Reuptake Inhibitors (SSRI) antidepressants may increase levels of apathy in neurodegenerative disorders and may have overall insufficient effect to alleviate levels of BPSD (Anand et al, 2018). Weighing risks and benefits, it is recognized that psychotropic agents should be prescribed with caution in dementia (Azuar and Levy, 2018;Phan et al, 2019).…”
Section: Introductionmentioning
confidence: 99%